RVPH Annual Accounts Payable
$3.85 M
+$328.80 K+9.34%
01 December 2023
Summary:
As of January 23, 2025, RVPH annual accounts payable is $3.85 million, with the most recent change of +$328.80 thousand (+9.34%) on December 1, 2023. During the last 3 years, it has risen by +$2.84 million (+281.86%). RVPH annual accounts payable is now at all-time high.RVPH Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RVPH Quarterly Accounts Payable
$8.78 M
+$4.08 M+87.02%
01 September 2024
Summary:
As of January 23, 2025, RVPH quarterly accounts payable is $8.78 million, with the most recent change of +$4.08 million (+87.02%) on September 1, 2024. Over the past year, it has increased by +$3.50 million (+66.29%). RVPH quarterly accounts payable is now at all-time high.RVPH Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RVPH Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.3% | +66.3% |
| 3 y3 years | +281.9% | +231.4% |
| 5 y5 years | +1614.5% | +231.4% |
RVPH Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +655.3% | at high | +1622.5% |
| 5 y | 5-year | at high | +1614.5% | at high | +2349.8% |
| alltime | all time | at high | +1614.5% | at high | +2349.8% |
Reviva Pharmaceuticals Holdings Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $8.78 M(+87.0%) |
| June 2024 | - | $4.69 M(-18.0%) |
| Mar 2024 | - | $5.72 M(+48.6%) |
| Dec 2023 | $3.85 M(+9.3%) | $3.85 M(-27.1%) |
| Sept 2023 | - | $5.28 M(+99.3%) |
| June 2023 | - | $2.65 M(-7.4%) |
| Mar 2023 | - | $2.86 M(-18.7%) |
| Dec 2022 | $3.52 M | $3.52 M(+49.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $2.35 M(-8.0%) |
| June 2022 | - | $2.55 M(+79.1%) |
| Mar 2022 | - | $1.43 M(+179.8%) |
| Dec 2021 | $509.60 K(-49.4%) | $509.60 K(+21.1%) |
| Sept 2021 | - | $420.80 K(+17.4%) |
| June 2021 | - | $358.30 K(-24.0%) |
| Mar 2021 | - | $471.30 K(-53.2%) |
| Dec 2020 | $1.01 M(+349.0%) | $1.01 M |
| Dec 2019 | $224.50 K | - |
FAQ
- What is Reviva Pharmaceuticals Holdings annual accounts payable?
- What is the all time high annual accounts payable for Reviva Pharmaceuticals Holdings?
- What is Reviva Pharmaceuticals Holdings annual accounts payable year-on-year change?
- What is Reviva Pharmaceuticals Holdings quarterly accounts payable?
- What is the all time high quarterly accounts payable for Reviva Pharmaceuticals Holdings?
- What is Reviva Pharmaceuticals Holdings quarterly accounts payable year-on-year change?
What is Reviva Pharmaceuticals Holdings annual accounts payable?
The current annual accounts payable of RVPH is $3.85 M
What is the all time high annual accounts payable for Reviva Pharmaceuticals Holdings?
Reviva Pharmaceuticals Holdings all-time high annual accounts payable is $3.85 M
What is Reviva Pharmaceuticals Holdings annual accounts payable year-on-year change?
Over the past year, RVPH annual accounts payable has changed by +$328.80 K (+9.34%)
What is Reviva Pharmaceuticals Holdings quarterly accounts payable?
The current quarterly accounts payable of RVPH is $8.78 M
What is the all time high quarterly accounts payable for Reviva Pharmaceuticals Holdings?
Reviva Pharmaceuticals Holdings all-time high quarterly accounts payable is $8.78 M
What is Reviva Pharmaceuticals Holdings quarterly accounts payable year-on-year change?
Over the past year, RVPH quarterly accounts payable has changed by +$3.50 M (+66.29%)